Abstract

SUMMARY There is great interest in developing universal guidelines for the diagnosis and treatment of gestational diabetes mellitus (GDM). This stems from the accumulating evidence that GDM is associated with significant risk of adverse outcomes for both mother and neonate. In recent years, the diagnostic thresholds for GDM have been lowered capturing a greater proportion of pregnant women with GDM. The timing and means by which pregnant women should be tested for GDM have not been well studied. Treatment aimed at reducing blood glucose levels appears to be effective in reducing risk of adverse outcomes. The most widely used methods by which to achieve treatment targets are lifestyle modification and insulin. Oral hypoglycemic agents are increasingly being used. There continues to be questions regarding treatment targets both during pregnancy and parturition. Given the increased risk of Type 2 diabetes in the future, it is important to educate women with GDM about the ongoing need for periodic testing for...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.